TA-104

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTA-104

Drug Alias Namerecombinant single domain monoclonal antibody fragment (Technophage)TA-104

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionBone modulators

TargetsUpdating

Therapy Area/IndicationsOsteoporosisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPortugal

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTechnophage SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTechnophage SA

Active IndicationsN/A

Inactive IndicationsOsteoporosisNeoplasms

Other Information

ATC CodeN/A